Author Question: Analysis of the NCS-R data indicated that a. most people who meet the criteria for a mental ... (Read 32 times)

savannahhooper

  • Hero Member
  • *****
  • Posts: 576
Analysis of the NCS-R data indicated that
 
  a. most people who meet the criteria for a mental disorder are in treatment.
  b. approximately 26 of Americans experience a mental disorder at some point in their life.
  c. mental disorders differ with respect to severity, and many people show only mild symptoms.
  d. all of these were related to the NCS-R data analysis.

Question 2

People with bipolar disorder tend to go in three different directions over time with about  of people eventually having good overall functioning.
 
  a. 10 to 15
  b. 50 to 60
  c. 15 to 20
  d. 25 to 50



AmberC1996

  • Sr. Member
  • ****
  • Posts: 317
Answer to Question 1

c

Answer to Question 2

c



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Allergies play a major part in the health of children. The most prevalent childhood allergies are milk, egg, soy, wheat, peanuts, tree nuts, and seafood.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

Approximately 15–25% of recognized pregnancies end in miscarriage. However, many miscarriages often occur before a woman even knows she is pregnant.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

For a complete list of videos, visit our video library